Mast cells as therapeutic target in cancer

被引:60
|
作者
Ribatti, Domenico [1 ,2 ]
机构
[1] Univ Bari, Sch Med, Dept Basic Med Sci Neurosci & Sensory Organs, Policlin Piazza G Cesare 11, I-70124 Bari, Italy
[2] Natl Canc Inst Giovanni Paolo II, Bari, Italy
关键词
Anticancer agents; Mast cells; Tryptase; Tumor growth; Tyrosine kinase inhibitors; TYROSINE KINASE INHIBITOR; BONE-MARROW ANGIOGENESIS; CHRONIC LYMPHOCYTIC-LEUKEMIA; ENDOTHELIAL GROWTH-FACTOR; HUMAN-BREAST-CANCER; CHORIOALLANTOIC MEMBRANE; SYSTEMIC MASTOCYTOSIS; TUMOR ANGIOGENESIS; TRYPTASE ACTIVITY; PULMONARY ADENOCARCINOMA;
D O I
10.1016/j.ejphar.2015.02.056
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mast cells promote tumorigenesis and tumor progression, and have functions that favor the host. Increased mast cell number correlates with a poor prognosis in several human tumors. In different vascular tumors, as well as a number of hematological and solid tumors, mast cell accumulation correlate with increased neovascularization, tumor aggressiveness, and metastatic spread. Mast cells might act as a new target for the adjuvant treatment of tumors through the selective inhibition of angiogenesis, tissue remodeling and tumor -promoting molecules, permitting the secretion of cytotoxic cytokines and preventing mast cell -mediated immune suppression. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:152 / 157
页数:6
相关论文
共 50 条
  • [31] CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's macroglobulinemia and mast cell disorders
    Santos, Daniel Ditzel
    Hatjiharissi, Evdoxia
    Tournilhac, Olivier
    Chemaly, Mariana Z. A.
    Leleu, Xavier
    Xu, Lian
    Patterson, Christopher
    Branagan, Andrew R.
    Manning, Robert J.
    Ho, Allen W.
    Hunter, Zachary R.
    Dimmock, Elizabeth A.
    Kutok, Jeffery L.
    Churchill, Winthrop H.
    Castells, Mariana C.
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    Treon, Steven P.
    CLINICAL LYMPHOMA & MYELOMA, 2006, 6 (06): : 478 - 483
  • [32] Mast cells and cancer
    Paolino, Giovanni
    Corsetti, Paola
    Moliterni, Elisa
    Corsetti, Serena
    Didona, Dario
    Albanesi, Marcello
    Mattozzi, Carlo
    Lido, Paolo
    Calvieri, Stefano
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2019, 154 (06): : 650 - 668
  • [33] Human Mast Cells From Adipose Tissue Target and Induce Apoptosis of Breast Cancer Cells
    Plotkin, Jesse D.
    Elias, Michael G.
    Fereydouni, Mohammad
    Daniels-Wells, Tracy R.
    Dellinger, Anthony L.
    Penichet, Manuel L.
    Kepley, Christopher L.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [34] Liver cancer stem cells: implications for a new therapeutic target
    Lee, Terence Kin Wah
    Castilho, Antonia
    Ma, Stephanie
    Ng, Irene Oi Lin
    LIVER INTERNATIONAL, 2009, 29 (07) : 955 - 965
  • [35] Metformin and prostate cancer stem cells: a novel therapeutic target
    Mayer, M. J.
    Klotz, L. H.
    Venkateswaran, V.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2015, 18 (04) : 303 - 309
  • [36] Proteases by reactive stromal cells in cancer:: an attractive therapeutic target
    Tetu, Bernard
    Trudel, Dominique
    Wang, Chang Shu
    BULLETIN DU CANCER, 2006, 93 (09) : 944 - 948
  • [37] Natural killer cells as a promising therapeutic target for cancer immunotherapy
    Kim, Nayoung
    Lee, Hyeon Ho
    Lee, Hyo-Jung
    Choi, Woo Seon
    Lee, Jinju
    Kim, Hun Sik
    ARCHIVES OF PHARMACAL RESEARCH, 2019, 42 (07) : 591 - 606
  • [38] Lymphoid tissue inducer cells in cancer: a potential therapeutic target
    Ashu Singh
    Alpana Sharma
    Molecular and Cellular Biochemistry, 2023, 478 : 2789 - 2794
  • [39] Iron control is a novel therapeutic target of cancer stem cells
    Ohara, Toshiaki
    Ninomiya, Takayuki
    Noma, Kazuhiro
    Kashima, Hajime
    Katsura, Yuki
    Kato, Takuya
    Tomono, Yasuko
    Tazawa, Hiroshi
    Kagawa, Shunsuke
    Shirakawa, Yasuhiro
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2016, 76
  • [40] Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
    Law, Andrew M. K.
    Valdes-Mora, Fatima
    Gallego-Ortega, David
    CELLS, 2020, 9 (03)